Public sector support services firm Tribal Group and SAS have entered into collaborative discussions to develop new software tools to support education improvement programmes in Tennessee.
"Both Tribal and SAS have existing contracts in the region which will benefit from this collaboration, with both companies excited by the wider potential of such products," Tribal explained in a company statement
Commenting on the deal, Tribal chief executive Keith Evans said: "Our skills in the area of evidence-based school improvement are complementary and we feel that, in combination, Tribal and SAS can make a significant contribution to the development of predictive tools for education improvement".
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Paula Henderson, Vice President, SAS State and Local Government Practice added:
"SAS provides both value-added analysis as well as student projections and a variety of diagnostic reporting. The system provides a valuable resource for professional development conversations with school administrators as well as important information to improve student outcomes."
"But teachers and administrators need to understand how to use the information effectively. Our collaboration with Tribal will be critical in training teachers and administrators to use value-added analyses to improve teaching and student performance," she added
CJ
-
Alchemy: gold for the gulliblePeople have fallen for alchemy for centuries, including Isaac Newton and Johannes Kepler. They should have known better
-
Vaccine maker shares slump after Trump picks RFK Jr as next US health secretaryDrugmakers' shares slumped after RFK Jr, a vaccine sceptic, was appointed as the next US Health Secretary. How will this affect drug companies?
